SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.

Highlights Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Equities

002603

CNE1000015S0

End-of-day quote Shenzhen S.E. Other stock markets 2024-09-09			5-day change	1st Jan Change
15.05 ^CNY	-0.79%		-0.66%	-34.76%

08-27	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
04-26	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	08-27	CI
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Implements Cash Dividend for the Year 2023, Payable on 19 July 2024	07-12	CI
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Cash Dividend Per 10 Shares for 2023	05-22	CI
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-26	CI
Yiling Pharmaceutical Gets Nod for China Clinical Trial of Tracheobronchitis Drug	12-06	MT
Yiling Pharmaceutical's Lianhua Qingke Tablets Gets Nod to Become Over-the-Counter Drug; Shares Up 4%	11-23	MT
Yiling Pharmaceutical Gets Nod to Trial Huoxia Cold Granules	11-17	MT
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Yiling Pharmaceutical Gets Green Light to Trial Acute Myeloid Leukemia Drug	23-10-24	MT
Yiling Pharmaceutical Gets Greenlight to Trial G201-Na Capsules	23-10-12	MT
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Announces Implementation of Cash Dividend for 2022, Payable on 17 July 2023	23-07-11	CI
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Cash Dividend for 2022	23-05-22	CI
Yiling Pharma's Hypertension Drug Passes Regulatory Evaluation in China	23-05-15	MT
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2022	23-04-26	CI
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Yiling Pharma Unit Gets Marketing Rights of Rujietai Capsules	23-03-02	MT
Yiling Pharma Gets Regulatory Nod for Traditional Chinese Medicine	23-02-03	MT
Yiling Pharma’s Traditional Chinese Medicine Added to Government's Recommended Drugs For COVID-19	23-01-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Equities

002603

CNE1000015S0

Highlights

Filters